A

AbCellera Biologics
D

ABCL

2.40000
USD
-0.08
(-3.23%)
مغلق
حجم التداول
160,959
الربح لكل سهم
-1
العائد الربحي
-
P/E
-4
حجم السوق
716,216,566
أصول ذات صلة
AMAT
AMAT
6.150
(4.13%)
155.060 USD
AMD
AMD
1.410
(1.45%)
98.770 USD
AVGO
AVGO
4.210
(2.11%)
203.420 USD
INTC
INTC
0.530
(2.64%)
20.590 USD
MRVL
MRVL
1.040
(1.70%)
62.310 USD
MU
MU
2.400
(3.07%)
80.680 USD
NVDA
NVDA
1.960
(1.74%)
114.400 USD
QCOM
QCOM
3.170
(2.32%)
139.770 USD
SWKS
SWKS
0.870
(1.33%)
66.090 USD
TSM
TSM
1.350
(0.76%)
179.220 USD
المزيد
الأخبار المقالات

العنوان: AbCellera Biologics

القطاع: Healthcare
الصناعة: Biotechnology
AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to theclinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.